台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    70.5
  • 漲跌
    ▼3.1
  • 漲幅
    -4.21%
  • 成交量
    379
  • 產業
    上櫃 生技醫療類股
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-元富-文心 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/2455606570758085May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富-文心 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/28371.7000.0070.5035700.53%
2025/03/2600.00474.9574.70-4577-0.69%
2025/03/2500.00274.7576.00-2594-0.34%
2025/03/24372.4000.0072.2035930.51%
2025/03/21172.5000.0072.4015940.17%
2025/03/20173.2000.0073.1015950.17%
2025/03/19173.2000.0072.6015980.17%
2025/03/18475.58375.5075.5016020.17%
2025/03/14178.1000.0077.7016170.16%
2025/03/12577.9000.0077.5055850.85%
2025/03/111879.0700.0081.50185573.23%
2025/03/1000.003.374.2576.80-3.3518-0.64%
2025/03/05169.70470.2568.90-3484-0.62%
2025/03/04168.70169.7069.6004830.00%
2025/02/21469.2500.0067.8045080.79%
2025/02/18162.3000.0062.6015020.20%
2025/02/1100.00163.1064.00-1594-0.17%
2025/02/0700.00160.8060.80-1589-0.17%
2025/01/221.160.4100.0060.901.16040.18%
2025/01/20159.4000.0061.0016160.16%
2025/01/17158.8000.0058.6016160.16%
2024/12/31166.0000.0064.3016690.15%
2024/12/26170.2000.0066.6016920.14%
2024/12/25175.8000.0074.0016830.15%
2024/12/2300.002.266.4066.40-2.2680-0.32%
2024/12/111.154.9000.0054.901.16660.17%
2024/12/093.163.06162.1062.002.16460.32%
2024/12/06764.8400.0064.3076511.07%
2024/12/0400.00567.1067.00-5655-0.76%
2024/11/29466.1800.0067.9046710.60%
2024/11/28164.6000.0064.8016720.15%
2024/11/270.166.7000.0066.500.16770.01%
2024/11/260.169.0000.0068.600.16810.01%
2024/11/22170.7000.0073.0016720.15%
2024/11/120.165.0000.0070.000.16320.02%
2024/11/110.270.5500.0070.100.26060.03%
2024/11/081.178.20181.5077.800.16030.02%
2024/11/06185.9000.0085.2016340.16%
2024/11/050.186.0000.0084.900.16360.02%
2024/11/04190.0000.0091.8016370.16%
2024/11/012.192.4700.0091.502.16530.32%
2024/10/300.195.0000.0093.800.16700.01%
2024/10/280.197.00194.7095.50-0.9688-0.13%
2024/10/240.2104.0000.00102.500.26970.03%
2024/10/211105.0300.00105.5017360.14%
2024/10/184.4111.0700.00110.004.47680.57%
2024/10/1400.001122.00121.00-1817-0.12%
2024/10/111.2115.5000.00114.501.28240.15%
2024/10/090.2122.0000.00119.000.28380.02%
2024/10/081.2122.1700.00126.001.28390.14%
2024/10/074115.5000.00116.5048300.48%
2024/09/301108.0000.00108.0017770.13%
2024/08/3000.000221.00216.0007920.00%
2024/08/230228.0000.00229.0007980.00%
2024/07/222166.250164.50164.0026670.30%
2024/07/180194.5000.00196.5006110.00%
2024/07/0800.001136.00138.50-1493-0.20%
2024/07/0500.001128.18127.50-1480-0.21%
2024/07/031125.5000.00124.5014740.21%
2024/07/011131.5000.00137.5014350.23%
2024/06/2000.001104.00105.00-1372-0.27%
2024/06/191102.0000.00101.5013740.27%
2024/06/1700.003102.00108.00-3353-0.85%
2024/06/0400.00197.5096.00-1316-0.32%
2024/05/27199.4000.00100.0013070.33%
2024/05/2400.00199.00105.00-1298-0.33%
2024/05/231100.5000.00100.5012860.35%
2024/05/2200.00193.4091.50-1260-0.38%
2024/05/21191.2000.0093.0012500.40%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音